Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Bases de dados
País/Região como assunto
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Environ Anal Health Toxicol ; 38(1): e2023005-0, 2023 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-37100400

RESUMO

Garri from cassava is one of the most consumed foods in West Africa, hence this research was conducted to examine microplastics (MPs) and potentially toxic elements (PTEs) in garri from Nigeria (West Africa) and Japan. This is the first investigation on MPs in garri samples that has been reported in the literature. The study analyzed both packaged and unpackaged vended garri samples using microscopic/spectroscopic and X-ray fluorescence techniques for MPs and PTEs respectively. Microplastic particles in the garri samples ranged from (or were between) 2.00±2.00 - 175.00±25.16 particles/50 with > 90 % as fragments and consisted of polyacrylamide, polyethylene terepthalate, polyvinyl alcohol, high density polyethylene, polyvinyl chloride acrylonitrile, polyethylene chlorinated, polypropylene with silicate mix, polychloroprene and polyethylene chlorosulphonated. The mean concentration of PTEs raged from ND to 0.07 mg/g for Cr and Mn, 0.73 to 5.63 mg/g for Fe, ND to 0.57mg/g for Co, 0.23 to 1.21 mg/g for Ni, 0.15 to 1.53 mg/g for Cu, and 0.12 to 0.63 mg/g for Zn. However, their daily intake was low for both adult and children as with the MPs. The sources of MPs and PTEs were mainly from the garri production processes, atmospheric dusts and during packaging. The non-carcinogenic risk for all samples was low for MPs while in openly vended garri, Ni and Cr in all sample poses carcinogenic risks. There is a need to improve indigenous garri processing techniques to minimize contamination. This research emphasizes the critical necessity to understand the consequences of MPs on human health.

2.
JAMA Netw Open ; 5(10): e2236053, 2022 10 03.
Artigo em Inglês | MEDLINE | ID: mdl-36219441

RESUMO

Importance: The global impact of COVID-19 has led to an increased need to continuously assess disease surveillance tools. The utility of SARS-CoV-2 serologic tools in determining immunity levels across different age groups and locations in helping to quickly assess the burden of COVID-19 with significant health policy implications is unknown. Objective: To determine the prevalence of SARS-CoV-2 antibodies with respect to the age group and sex of participants. Design, Setting, and Participants: A cross-sectional survey of 4904 individuals across 12 states with high and low COVID-19 disease burden in Nigeria was carried out between June 29 and August 21, 2021. Main Outcomes and Measures: Enzyme-linked immunosorbent assay was used for the detection of specific SARS-CoV-2 immunoglobulin G and immunoglobulin M antibodies, such as the nucleocapsid protein-NCP and spike protein S1. Interviewer-administered questionnaires provided information on participants' history of disease and associated risk factors. Results: A total of 4904 individuals participated in the study (3033 were female [61.8%]; mean [SD] age, 26.7 [6.51] years). A high seroprevalence of SARS-CoV-2 (78.9%) was obtained. Seropositivity was consistent across the states surveyed, ranging from 69.8% in Lagos to 87.7% in Borno. There was no association between sex and seropositivity (female, 2414 [79.6%]; male, 1456 [77.8%]; P = .61); however, an association was noted between age and seropositivity, with the peak prevalence observed in participants aged 15 to 19 years (616 [83.6%]; P = .001). Similarly, loss of appetite (751 [82.3%]; P = .04) and smell (309 [84.4%]; P = .01) were associated with seropositivity. Conclusions and Relevance: In this cross-sectional study, a high SARS-CoV-2 seroprevalence was obtained among the study population during the low level of vaccination at the time of the survey. Thus, there is a need for both an efficacy and antibody neutralization test study to ascertain the efficacy of the antibody detected and the potential for herd immunity in Nigeria.


Assuntos
COVID-19 , SARS-CoV-2 , Adulto , COVID-19/epidemiologia , Efeitos Psicossociais da Doença , Estudos Transversais , Feminino , Humanos , Imunoglobulina G , Imunoglobulina M , Masculino , Nigéria/epidemiologia , Proteínas do Nucleocapsídeo , Estudos Soroepidemiológicos , Glicoproteína da Espícula de Coronavírus
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA